AlTi Global’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.65M Buy
18,051
+273
+2% +$23.9K 0.03% 201
2026
Q1
$1.52M Buy
17,778
+227
+1% +$20.2K 0.03% 188
2025
Q4
$1.39M Buy
17,551
+5,814
+50% +$456K 0.03% 196
2025
Q3
$938K Buy
11,737
+8,699
+286% +$742K 0.02% 253
2025
Q2
$276K Buy
3,038
+661
+28% +$60.3K 0.01% 368
2025
Q1
$223K Sell
2,377
-619
-21% -$55.4K 0.01% 366
2024
Q4
$272K Buy
2,996
+599
+25% +$57.2K 0.01% 358
2024
Q3
$249K Sell
2,397
-1,884
-44% -$192K 0.01% 346
2024
Q2
$415K Buy
4,281
+119
+3% +$11K 0.01% 277
2024
Q1
$375K Buy
+4,162
New +$353K 0.01% 289

Other funds holding CL

AlTi Global's CL Position: Q2 2026 in Review

AlTi Global increased its Colgate-Palmolive (CL) stake by 1.5% in Q2 2026, buying an estimated $23.9K and bringing the position to 18,051 shares worth $1.65M. The position accounts for 0.03% of the portfolio, ranked #201.

AlTi Global first reported a position in CL in Q1 2024 and has held it in 10 quarters since. 2,017 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • AlTi Global held 18,051 shares of Colgate-Palmolive worth $1.65M as of Q2 2026.
  • AlTi Global bought 273 Colgate-Palmolive shares in Q2 2026, an estimated $23.9K.
  • Colgate-Palmolive made up 0.03% of AlTi Global's portfolio in Q2 2026, its #201 holding.
  • AlTi Global first reported a position in Colgate-Palmolive in Q1 2024 and has held it in 10 quarters since.
  • 2,017 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on AlTi Global's 13F filing for Q2 2026, filed 5 Aug 2026.